High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy
- PMID: 29018161
- DOI: 10.1136/jnnp-2017-316689
High prevalence of the MYD88 L265P mutation in IgM anti-MAG paraprotein-associated peripheral neuropathy
Keywords: genetics; myelin; neurooncology; paraproteinaemia; peripheral neuropathology.
Conflict of interest statement
Competing interests: MJK has consulted for or received compensation for presentations from Gilead, Celgene, Novartis, Roche, Millennium/Takeda, Kite Pharma and BMS, and has received research support from Celgene, Roche, Millennium and Sanofi. SD has received honoraria from Janssen. MPL has received honoraria from CSL Behring Grifols, UCB Pharma, Baxter and LfB. MCM has consulted for Jansen Cilag, Takeda, Amgen, BMS. The other authors had no disclosures to report.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials